Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (271-280 of 326) with videos related to

Pageof 33
Sort By:
Hepatology (Baltimore, Md.)|April 4, 2017
Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 yearsJames Fung, Tiffany Wong, Kenneth Chok, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis CohortJasmohan S Bajaj, Scott Silvey, Aidan Mullan, et al.
The American Journal of Gastroenterology|September 21, 2016
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, Danny Ka-Ho Wong, Thomas Sau-Yan Chan, et al.
The International Journal on Drug Policy|August 31, 2024
Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: Barriers and facilitatorsLung-Yi Mak, Wai-Pan To, Vivien Tsui, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 24, 2023
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver diseaseChao Sun, George Boon-Bee Goh, Wan-Cheng Chow, et al.
Helicobacter|November 6, 2009
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?Ivan F N Hung, Pierre Chan, Sally Leung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2020
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver diseaseXinrong Zhang, George B-B Goh, Wah-Kheong Chan, et al.
Journal of Viral Hepatitis|January 6, 2023
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia studyYong-Wen Leow, Wah-Kheong Chan, George Boon-Bee Goh, et al.
Gut|August 3, 2010
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor populationMan-Fung Yuen, Cheuk-Kwong Lee, Danny Ka-Ho Wong, et al.
The Journal of Infectious Diseases|January 23, 2019
A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong KongKevin S H Liu, Wai-Kay Seto, Eric H Y Lau, et al.
Pageof 33

Showing results (271-280 of 326) with videos related to

Sort By:
Pageof 33
Hepatology (Baltimore, Md.)|April 4, 2017
Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 yearsJames Fung, Tiffany Wong, Kenneth Chok, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2025
Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis CohortJasmohan S Bajaj, Scott Silvey, Aidan Mullan, et al.
The American Journal of Gastroenterology|September 21, 2016
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive TherapyWai-Kay Seto, Danny Ka-Ho Wong, Thomas Sau-Yan Chan, et al.
The International Journal on Drug Policy|August 31, 2024
Pilot model of hepatitis C virus micro-elimination in high-risk populations in Hong Kong: Barriers and facilitatorsLung-Yi Mak, Wai-Pan To, Vivien Tsui, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 24, 2023
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver diseaseChao Sun, George Boon-Bee Goh, Wan-Cheng Chow, et al.
Helicobacter|November 6, 2009
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?Ivan F N Hung, Pierre Chan, Sally Leung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2020
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver diseaseXinrong Zhang, George B-B Goh, Wah-Kheong Chan, et al.
Journal of Viral Hepatitis|January 6, 2023
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia studyYong-Wen Leow, Wah-Kheong Chan, George Boon-Bee Goh, et al.
Gut|August 3, 2010
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor populationMan-Fung Yuen, Cheuk-Kwong Lee, Danny Ka-Ho Wong, et al.
The Journal of Infectious Diseases|January 23, 2019
A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong KongKevin S H Liu, Wai-Kay Seto, Eric H Y Lau, et al.
Pageof 33